Immunovant
IMVT
$29.39
Share price
-1.04%
Change (1 day)
63.73%
Change (1 year)
Categories
Earnings for Immunovant (IMVT)
Earnings in 2023 (TTM): -$0.26 B
According to Immunovant's latest financial reports the company's current earnings (TTM) are -$0.26 B. In 2022 the company made an earning of -$0.2 B a decrease over its 2021 earnings that were of -$0.14 B.The earnings displayed on this page is the company's Pretax Income.
Earnings history for Immunovant from 2019 to 2023
Annual earnings
| Year | Earnings | Change |
|---|---|---|
2023 (TTM)  | -$0.26 B | 32.6% |
| 2022 | -$0.2 B | 39.55% |
| 2021 | -$0.14 B | 37.3% |
| 2020 | -$99.81 M | 780.74% |
| 2019 | -$11.34 M |
Earnings for similar companies or competitors
| Company | Earnings | Earnings differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | -$0.12 B | -56.32% | 🇺🇸 USA |